The immune tolerance network: a new paradigm for developing tolerance-inducing therapies.

  title={The immune tolerance network: a new paradigm for developing tolerance-inducing therapies.},
  author={D. Rotrosen and J. B. Matthews and J. Bluestone},
  journal={The Journal of allergy and clinical immunology},
  volume={110 1},
  • D. Rotrosen, J. B. Matthews, J. Bluestone
  • Published 2002
  • Medicine
  • The Journal of allergy and clinical immunology
  • Immune tolerance therapies are designed to reprogram immune cells in a highly specific fashion to eliminate pathogenic responses while preserving protective immunity. A concept that has tantalized immunologists for decades, the development of tolerance-inducing therapies, would revolutionize the management of a wide range of chronic and often debilitating diseases by obviating the need for lifelong immunosuppressive regimens. The advances of the past decade have provided a more detailed… CONTINUE READING
    41 Citations
    The immunological monitoring of alloreactive responses in liver transplant recipients: A review
    • 28
    Frontiers in nephrology: immune tolerance to allografts in humans.
    • 42
    • PDF
    Transplantation tolerance in pediatric recipients: Lessons and challenges
    • 12
    Tolerance induction in clinical transplantation: the pending questions
    • 30
    Overview of Immunity
    • 5
    T-Cell Maturation and Activation
    • 7
    • PDF


    Transplantation tolerance: mechanisms and strategies?
    • 18
    Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms.
    • 77
    CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    • A. Kirk, D. Harlan, +7 authors S. Knechtle
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1997
    • 919
    • PDF